Alterations in overall body composition ended up evaluated in a very sub-review in SURMOUNT-one working with dual Power X-ray absorptiometry (DEXA). The final results on the DEXA assessment confirmed that therapy with tirzepatide was accompanied by greater reduction in fat mass than in lean overall